77 related articles for article (PubMed ID: 7712576)
1. [Molecular degradation forms of plasma fibronectin in patients with chronic obstructive pulmonary disease].
Ding YH; Lu YQ; Cheng JG
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):305-7, 320. PubMed ID: 7712576
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of fibronectin and protease inhibitors in chronic obstructive pulmonary diseases].
Dong BR
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Dec; 12(6):343-6, 381. PubMed ID: 2483984
[TBL] [Abstract][Full Text] [Related]
3. [The changes in collagen contents and its clinical significance in chronic obstructive pulmonary disease].
Dong B; Zhou J; Wang Z
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):301-2, 319. PubMed ID: 8762485
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
[TBL] [Abstract][Full Text] [Related]
5. [The clinical manifestations and the plasma levels of fibronectin and fibrin-fibrinogen degradation products in different morphological forms of chronic hepatitis].
Malaia LT; Iabluchanskiĭ NI; Panchuk SN; Babak OIa
Ter Arkh; 1991; 63(11):44-6. PubMed ID: 1810062
[TBL] [Abstract][Full Text] [Related]
6. Presence of high-molecular-weight forms and domain alterations of fibronectin in pleural effusion of patients with lung cancer.
Pupek M; Krzyzanowska-Gołab D; Dyła T; Lemańska-Perek A; Jankowska R; Katnik-Prastowska I
Clin Biochem; 2009 May; 42(7-8):654-61. PubMed ID: 19161998
[TBL] [Abstract][Full Text] [Related]
7. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression.
Przybysz M; Borysewicz K; Szechinski J; Katnik-Prastowska I
Rheumatology (Oxford); 2007 Jul; 46(7):1071-5. PubMed ID: 17459959
[TBL] [Abstract][Full Text] [Related]
8. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin fragments cause an underestimation of plasma fibronectin levels in severe pre-eclampsia.
De Jager CA; Anthony J; Robson SC; Shephard EG; Kirsch RE
Scand J Clin Lab Invest; 1996 Jul; 56(4):351-8. PubMed ID: 8837242
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical mechanisms of thoracic fibrosis development after pneumonectomy in patients operated for progressive pulmonary tuberculosis].
Kaminskaia GO; Grigor'eva EV; Testov VV
Probl Tuberk; 1999; (1):51-4. PubMed ID: 10199187
[TBL] [Abstract][Full Text] [Related]
11. [Determination of plasma endothelin-1 in aged patients with chronic obstructive pulmonary disease in its clinical significance].
Feng CS; Huang NQ; Zeng Q
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Oct; 16(5):287-9, 320. PubMed ID: 7923434
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of soluble supra-molecular FN-fibrin complexes in the plasma of children with recurrent respiratory infection.
Lemańska-Perek A; Polańska B; Krzyżanowska-Gołąb D; Kątnik-Prastowska I
Ann Clin Biochem; 2015 Jul; 52(Pt 4):441-7. PubMed ID: 25293592
[TBL] [Abstract][Full Text] [Related]
13. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Zhao HW; Lu CJ; Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776
[TBL] [Abstract][Full Text] [Related]
14. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations].
Mispelaere D; Glerant JC; Audebert M; Remond A; Sevestre-Pietri MA; Jounieaux V
Rev Mal Respir; 2002 Sep; 19(4):415-23. PubMed ID: 12417857
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin fragments in human seminal plasma.
Katnik-Prastowska I; Przybysz M; Chełmońska-Soyta A
Acta Biochim Pol; 2005; 52(2):557-60. PubMed ID: 15912204
[TBL] [Abstract][Full Text] [Related]
17. Distribution of fibronectin isoforms in human renal disease.
Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
[TBL] [Abstract][Full Text] [Related]
18. [Plasma fibronectin in chronic liver diseases].
Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
[TBL] [Abstract][Full Text] [Related]
19. Depression of phagocytosis by plasmin degradation products of plasma fibronectin.
Ehrlich MI; Krushell JS; Blumenstock FA; Kaplan JE
J Lab Clin Med; 1981 Aug; 98(2):263-71. PubMed ID: 7252334
[TBL] [Abstract][Full Text] [Related]
20. [Review. The intensive medical care relevance of plasma fibronectin].
Lundsgaard-Hansen P; Doran JE; Rubli E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):435-45. PubMed ID: 2431963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
